Ozempic may be able to help people quit smoking and potentially reduce the need for additional anti-smoking aids, a new study claims.
Researchers from Case Western Reserve School of Medicine examined how effectively Ozempic helps people with type 2 diabetes quit smoking, in comparison to seven other anti-diabetic medications.
The study, published in the Annals of Internal Medicine, was inspired by reports from previous Ozempic users, not involved in the research, who noted a decreased desire to smoke while taking the medication.
More From Newsweek Vault: What Is a Health Savings Account?
These reports sparked interest in exploring Ozempic’s potential benefits for treating tobacco use disorders (TUD).
A spokesperson from Novo Nordisk, the Danish pharmaceutical giant behind Ozempic, told Newsweekthat the company welcomes independent research into the safety, efficacy, and clinical utility of its products. However, they emphasized …